The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase.
Ciesek
Sandra
S
Steinmann
Eike
E
Manns
Michael P
MP
Wedemeyer
Heiner
H
Pietschmann
Thomas
T
D000998:Antiviral Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology*; D000068876:Fingolimod Hydrochloride; D016174:Hepacivirus / Q000187:drug effects*; D011409:Propylene Glycols / Q000494:pharmacology; D012367:RNA, Viral / Q000096:biosynthesis*; D051102:Serine C-Palmitoyltransferase / Q000037:antagonists & inhibitors*; D013110:Sphingosine / Q000031:analogs & derivatives / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D005229:Fatty Acids, Monounsaturated; D011409:Propylene Glycols; D012367:RNA, Viral; D051102:Serine C-Palmitoyltransferase; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; C001996:thermozymocidin